Searched for
ECONOMIC IMPACT ON INDIAN PHARMA
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Why is market falling today? 7 triggers behind 800-point Sensex fall, Rs 4 lakh crore wealth wipeoutIndian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barre...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
- Europe heatwave: The thermometer is flashing red for the continent's economyEurope's heatwave is becoming a growing economic threat as extreme temperatures disrupt transport, reduce labour productivity, damage agric...
- MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusionsMSCI’s August India Standard Index review could trigger major passive inflows, with Eternal expected to attract the highest at $648 million...
- Rupee weakens to two-month low as oil climbs; state-run banks cushionThe Indian rupee reached its weakest point in two months on Monday. Rising oil prices and Middle East hostilities pressured the currency's ...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- BBBump it up, boys! The great Indian economic rating puzzleIndia's fiscal discipline has improved significantly, supported by strong economic growth. Government deficit has narrowed while growth con...
- The economic goal that never came: World Cup falls short of boosting MexicoThe recent World Cup brought excitement but did not significantly boost Mexico's economy. Weak investment and trade agreement uncertainty c...
- Why did market rise today? Sensex surges 965 points; Nifty ends above 24,300. 4 reasons why D-Street defied global routIndian stock markets saw gains on Friday, with Sensex and Nifty trading higher. IT stocks led the gains, while broader markets experienced ...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one yearFredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify....
- Sensex falls 500 points, Nifty slips below 24,100 as US-Iran conflict escalates. What lies ahead?Indian stock markets edged lower on Tuesday, with major indices Sensex and Nifty falling. Escalating Middle East tensions contributed to ri...
Load More
